Get alerts on new MANKIND PHARMA LIMITED bonds
Top yield
7.66%
latest traded
Trading now
2
of 2 live
Instruments
2
outstanding
Top rating
AA+
latest
Traded yield by time to maturity
Each point is a different security, so the line is a shape, not an apples-to-apples curve. Yields are not directly comparable: seniority, security cover and collateral, put and call options, step-ups and covenants all differ line to line. Read each security on its own terms.
| The latest agency surveillance grade where one is on record; otherwise the grade at issue. A rating can migrate after issuance, so the two can differ. | ||||
|---|---|---|---|---|
Mankind PharmaINE634S07033NCD | AA+ | 7.97% | 16 Nov 20271.2y left | 7.66% |
Mankind PharmaINE634S07025NCD | AA+ | 7.99% | 16 Oct 20261mo left | 6.97% |
Secured: backed by a charge over the issuer's assets. Unmarked lines are unsecured.
Click any security to compare it across platforms against the live exchange-traded yield. A blank yield means no recent trade, not no value.
Keep exploring
Comparisons
Sammaan Capital17 buyable · up to 9.71%
Indel Money9 buyable · up to 12.40%
Navi Finserv9 buyable · up to 11.25%
Earlysalary Services8 buyable · up to 11.25%
Muthoot Fincorp8 buyable · up to 10.50%
Insights
- Rating actions
upgrades & downgrades
- G-Sec yield curve
- Debt market review
- How to play the tenor
Guide · part 2
Capera
Neutrality
Guarantee
Neutrality guarantee
Prices you can't pay to move.
Capera is editorially independent. We may earn from the platforms and institutions we list, but a commercial arrangement never changes the price or yield we show you.